| Recruiting | GRASS (Grass MATA MPL Real-world Assessment Study) Grass Pollen Allergy | — | 2026-03-11 |
| Active Not Recruiting | Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects Peanut Allergy | Phase 1 | 2022-10-17 |
| Completed | Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced Seasonal Allergic Rhinitis, Rhinoconjunctivitis | Phase 3 | 2022-10-11 |
| Completed | Effect of holoBLG on Cat Allergic Patients Allergy to Cats, Allergic Rhinoconjunctivitis | N/A | 2021-10-04 |
| Active Not Recruiting | Tyrosine Allergoid Paediatric and Adult Study Allergic Rhinitis Due to Pollen, Allergic Conjunctivitis, Allergic Asthma | — | 2020-11-06 |
| Completed | An Exploratory Study of PQ Grass 27600 SU Rhinitis, Allergic, Seasonal | Phase 2 / Phase 3 | 2020-10-19 |
| Completed | Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglob Rhinitis, Allergic, Respiratory Tract Infections, Allergy | — | 2020-04-22 |
| Completed | A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL Seasonal Allergic Rhinitis | Phase 1 | 2017-01-16 |
| Completed | Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™ Seasonal Allergic Rhinitis | Phase 2 | 2015-11-07 |
| Completed | A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL Allergic Rhinitis | Phase 1 | 2015-08-01 |
| Completed | Efficacy and Safety/Tolerability of Ragweed MATA MPL Type I Hypersensitivity | Phase 3 | 2007-03-01 |
| Completed | Efficacy and Safety/Tolerability of Grass MATA MPL Type I Hypersensitivity | Phase 3 | 2006-11-01 |
| Terminated | Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Sea Type I Hypersensitivity | Phase 2 | 2006-10-01 |
| Completed | Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal A Type I Hypersensitivity | Phase 2 | 2006-05-01 |
| Completed | Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen Type I Hypersensitivity | Phase 1 | 2005-12-01 |
| Completed | Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Usi Type I Hypersensitivity | Phase 2 | 2005-11-01 |
| Completed | Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sens Type I Hypersensitivity | Phase 2 | 2005-09-12 |
| Completed | Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine Type I Hypersensitivity | Phase 2 | 2005-09-12 |
| Completed | Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensi Type I Hypersensitivity | Phase 2 | 2005-07-07 |
| Completed | Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine Type I Hypersensitivity | Phase 2 | 2005-07-01 |
| Completed | Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen Type I Hypersensitivity | Phase 2 | 2005-07-01 |
| Completed | Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Type I Hypersensitivity | Phase 1 | 2005-06-01 |
| Completed | Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Aller Type I Hypersensitivity | Phase 2 | 2005-05-01 |
| Withdrawn | Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl L Type I Hypersensitivity | Phase 1 | 2005-05-01 |
| Completed | Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testi Type I Hypersensitivity | Phase 1 | 2005-04-01 |
| Completed | Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing Type I Hypersensitivity | Phase 1 | 2005-03-01 |
| Completed | Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen Type I Hypersensitivity | Phase 2 | 2005-03-01 |